Integrated signatures define mutational processes in prostate cancer

Researchers identified eight integrated mutational footprints that collectively explain the mutational landscape of 85% of primary prostate cancer genomes. Published in Nature, the study combines multiple layers of genomic data into unified signatures, providing a comprehensive framework for understanding how mutations accumulate in prostate tumors. The findings could improve patient stratification and guide future therapeutic strategies based on dominant mutational processes.